210 related articles for article (PubMed ID: 25340299)
1. Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor.
Homan KT; Wu E; Cannavo A; Koch WJ; Tesmer JJ
Molecules; 2014 Oct; 19(10):16937-49. PubMed ID: 25340299
[TBL] [Abstract][Full Text] [Related]
2. Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors.
Homan KT; Larimore KM; Elkins JM; Szklarz M; Knapp S; Tesmer JJ
ACS Chem Biol; 2015 Jan; 10(1):310-9. PubMed ID: 25238254
[TBL] [Abstract][Full Text] [Related]
3. Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.
Waldschmidt HV; Bouley R; Kirchhoff PD; Lee P; Tesmer JJG; Larsen SD
Bioorg Med Chem Lett; 2018 May; 28(9):1507-1515. PubMed ID: 29627263
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.
Homan KT; Waldschmidt HV; Glukhova A; Cannavo A; Song J; Cheung JY; Koch WJ; Larsen SD; Tesmer JJG
J Biol Chem; 2015 Aug; 290(34):20649-20659. PubMed ID: 26032411
[TBL] [Abstract][Full Text] [Related]
5. Generation of Highly Selective, Potent, and Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.
Rowlands RA; Chen Q; Bouley RA; Avramova LV; Tesmer JJG; White AD
J Med Chem; 2021 Jan; 64(1):566-585. PubMed ID: 33393767
[TBL] [Abstract][Full Text] [Related]
6. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2
Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS
Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for small molecule inhibition of G protein-coupled receptor kinases.
Homan KT; Tesmer JJ
ACS Chem Biol; 2015 Jan; 10(1):246-56. PubMed ID: 24984143
[TBL] [Abstract][Full Text] [Related]
8. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.
Bouley R; Waldschmidt HV; Cato MC; Cannavo A; Song J; Cheung JY; Yao XQ; Koch WJ; Larsen SD; Tesmer JJG
Mol Pharmacol; 2017 Dec; 92(6):707-717. PubMed ID: 29070696
[TBL] [Abstract][Full Text] [Related]
9. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy.
Lieu M; Koch WJ
Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991
[TBL] [Abstract][Full Text] [Related]
10. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK
Beyett TS; Gan X; Reilly SM; Chang L; Gomez AV; Saltiel AR; Showalter HD; Tesmer JJG
Mol Pharmacol; 2018 Oct; 94(4):1210-1219. PubMed ID: 30082428
[TBL] [Abstract][Full Text] [Related]
11. GRK5 Inhibition Attenuates Cartilage Degradation via Decreased NF-κB Signaling.
Sueishi T; Akasaki Y; Goto N; Kurakazu I; Toya M; Kuwahara M; Uchida T; Hayashida M; Tsushima H; Bekki H; Lotz MK; Nakashima Y
Arthritis Rheumatol; 2020 Apr; 72(4):620-631. PubMed ID: 31696655
[TBL] [Abstract][Full Text] [Related]
12. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.
Beyett TS; Gan X; Reilly SM; Gomez AV; Chang L; Tesmer JJG; Saltiel AR; Showalter HD
Bioorg Med Chem; 2018 Nov; 26(20):5443-5461. PubMed ID: 30270002
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog.
Homan KT; Wu E; Wilson MW; Singh P; Larsen SD; Tesmer JJ
Mol Pharmacol; 2014 Feb; 85(2):237-48. PubMed ID: 24220010
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
16. Localization of the sites for Ca2+-binding proteins on G protein-coupled receptor kinases.
Levay K; Satpaev DK; Pronin AN; Benovic JL; Slepak VZ
Biochemistry; 1998 Sep; 37(39):13650-9. PubMed ID: 9753452
[TBL] [Abstract][Full Text] [Related]
17. Atomic Structure of GRK5 Reveals Distinct Structural Features Novel for G Protein-coupled Receptor Kinases.
Komolov KE; Bhardwaj A; Benovic JL
J Biol Chem; 2015 Aug; 290(34):20629-20647. PubMed ID: 26032409
[TBL] [Abstract][Full Text] [Related]
18. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro.
Inagaki S; Ghirlando R; Vishnivetskiy SA; Homan KT; White JF; Tesmer JJ; Gurevich VV; Grisshammer R
Biochemistry; 2015 Jul; 54(28):4320-9. PubMed ID: 26120872
[TBL] [Abstract][Full Text] [Related]
19. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.
Martini JS; Raake P; Vinge LE; DeGeorge BR; Chuprun JK; Harris DM; Gao E; Eckhart AD; Pitcher JA; Koch WJ
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12457-62. PubMed ID: 18711143
[TBL] [Abstract][Full Text] [Related]
20. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain.
Pronin AN; Satpaev DK; Slepak VZ; Benovic JL
J Biol Chem; 1997 Jul; 272(29):18273-80. PubMed ID: 9218466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
